Havrix 1,440 unit/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FGXNR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,921
Award facts
- Contract value 100% obligated
- $2,920.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Havrix 1,440 unit/mL syringes, a hepatitis A vaccine product. This firm fixed price delivery order, valued at $2,920.87, is classified as a non-set-aside competitive award with an ultimate completion date of August 19, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), an expansive $999.99 billion prime vendor agreement running through December 2026 that supports global pharmaceutical distribution for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contracts encompasses a comprehensive range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities delivered through the Defense Logistics Agency's Medical Supply Chain. This award continues the contractor's role in supplying essential medical products, including vaccines and injectable pharmaceuticals, to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order reflects the contractor's demonstrated capability to meet federal procurement requirements through open competition and its participation in DLA's strategic pharmaceutical prime vendor programs.
Quick answers
Who was awarded contract SPE2DB25FGXNR?
SPE2DB25FGXNR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FGXNR worth?
The government has obligated $2,921 on SPE2DB25FGXNR.
Is contract SPE2DB25FGXNR an order under another contract?
Yes. SPE2DB25FGXNR is a delivery order under SPE2DB24D2213, an indefinite delivery contract.
Was contract SPE2DB25FGXNR competed?
The extent of competition for SPE2DB25FGXNR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award